M&A Deal Summary |
|
|---|---|
| Date | 2025-09-10 |
| Target | Volta Labs - Callisto Platform |
| Sector | Life Science |
| Buyer(s) | Prinses Maxima Center |
| Sellers(s) | Volta Labs |
| Deal Type | Divestiture |
SEARCH BY
Prinses Maxima Center provides an integrated combination of specialized pediatric cancer care, scientific research, and education/training. Prinses Maxima Center is based in Utrecht, Netherlands.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Life Science M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 1 of 1 |
| State: Massachusetts M&A | 1 of 1 |
| Country: United States M&A | 1 of 1 |
| Year: 2025 M&A | 1 of 1 |
Volta Labs is a genomics applications company that has developed a cutting-edge digital fluidics platform to maximize the performance and scalability of sample preparation in genomics while providing unparalleled consistency. Volta Labs is based in Boston, Massachusetts.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Life Science M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 1 of 1 |
| State: Massachusetts M&A | 1 of 1 |
| Country: United States M&A | 1 of 1 |
| Year: 2025 M&A | 1 of 1 |